Nov. 13 at 9:37 PM
$OM Here are the recent Outset Medical (OM) price targets by notable brokers following the latest results:
Stifel Nicolaus: Price target lowered to
$14 from
$17, maintaining a Buy rating due to softer consumable sales and lowered full-year guidance but citing a strong pipeline for future performance.
BTIG Research: Price target set at
$37, previously lowered from
$39, with a Buy rating highlighting growth potential despite recent challenges.
Royal Bank of Canada (RBC Capital): Sector Perform rating with a price target of
$22, maintaining this target in recent updates.
Weiss Ratings: Reiterated a Sell rating with a lower price target at
$8, indicating a negative outlook.
$CMPS $KRRO
